infantis JCM 1222 has been shown to directly act on IECs to suppress CD80 and CD40 expression, and subsequently resulting in the suppression of mRNA and protein expression levels of IL-17A and alleviation of colitis [32]. This evidence concerns the gene IL17A and colitis.